摘要 |
<p>Peptides and peptide derivatives of the following general Formula (I) H2N-GHRPX1X2X3X4X5X6X7X8PX9X10X11PX12PPPX13X14X15X16GYR-X17, wherein: X1 - X16 denote one of the 20 genetically encoded amino acids, X17 denotes OR1, with R1 = hydrogen or (C1-C10-alkyl), or NR2R3, R2 and R3 being identical or different and denoting hydrogen, (C1-C10)-alkyl, or a residue -PEG5-60K, wherein the PEG-residue is linked to the N atom via a spacer, or a residue NH-Y-Z-PEG5-60K, wherein Y denotes a chemical bond or a genetically coded amino acid from among the group of S, C, K or R, and Z denotes a spacer by way of which a polyethylene glycol (PEG)-residue may be linked, as well as the physiologically acceptable salts thereof, or wherein: X15 or X16 denotes an amino acid from the group of C or K, which is linked to a residue Z-PEG5-60K via the heteroatom in the side chain, and wherein X17 denotes OR1, with R1 = hydrogen or (C1-C10- alkyl), or NR2R3, R2 and R3 being identical or different and denoting hydrogen or (C1-C10)-alkyl, as well as the physiologically acceptable salts thereof.</p> |
申请人 |
FIBREX MEDICAL RESEARCH & DEVELOPMENT GMBH;PETZELBAUER, PETER;REINGRUBER, SONJA;PASTEINER, WALTRAUD;HENNING, RAINER |
发明人 |
PETZELBAUER, PETER;REINGRUBER, SONJA;PASTEINER, WALTRAUD;HENNING, RAINER |